Board Type
Posts Today
Posts Last 30 Days







Company Information:

48th Floor, Bank of China Tower

1 Garden Road
Hong Kong S.A.R.
(852) 3605-8180


CIK 0001467808


Formerly Pantheon China Acquisition Corp.

CHINA CORD BLOOD CORPORATION, a leading provider of cord blood banking services in China. Expectant parents pay us to process and store the cord blood of their children at birth for potential future use in medical treatment of the children or their family members. The payment structure of our contracts with subscribers enable us to enjoy a steady stream of long term cash inflows from annual storage fees. We enter into 18-year-contracts with our subscribers and charge an initial processing fee at birth and a storage fee each year. These contracts can be terminated early by the parents or further extended, at the option of the children, after the children reach adulthood. We expect annual storage fees to contribute an increasing proportion of our revenue as the number of our subscribers accumulated over the years continues to grow. In addition to our fee-based commercial services, we also preserve cord blood units donated by the public and charge fees for matching units provided for patients in need of transplants. This revenue accounts for a small percentage of our total revenue.


The PRC government authorities have been following a "one license per region" policy, allowing each licensee, including us, to operate within its own region without competition. The application process for a cord blood banking license takes several years, during which time the applicant usually incurs a substantial amount of initial investments, including constructing cord blood bank facilities to demonstrate to the government authorities that it is capable of meeting the stringent application requirements. This licensing process may deter newcomers with fewer resources and less experience from competing for licenses with established cord blood banking operators in China.


Our management team successfully pioneered the commercialization of cord blood banking services in China. Jiachenhong, our Beijing-based subsidiary with operations dating back to 2002, was the operator of the first licensed cord blood bank in China. We have also developed a hospital network consisting of over 90 major hospitals in Beijing to perform cord blood collection services for our subscribers. To expand the geographic coverage of our business, we acquired the right to operate in Guangdong through the acquisition of Nuoya in May 2007. The acquisition enabled us to significantly increase the size of the market that we can address. We believe we will be able to apply the experience we gained in our successful operation in Beijing to our more recently commenced operation in Guangdong. As of June 30, 2009, we had capacity to store approximately 645,000 additional units, and we believe we have the ability to further expand our capacity to meet the increasing market demand.


Currently, we are the sole cord blood banking licensee in Beijing and Guangdong. So far, cord blood banking licenses have been issued for only six of China's 31 regions, with another four licenses expected to be issued by 2010. We expect to continue to grow our business through existing market penetration and geographical expansion. Our existing operations cover an aggregate population of approximately 110 million, including 94 million in Guangdong, which is larger than all but 12 countries in the world. According to the National Bureau of Statistics of China, there were 1.2 million newborns in Beijing and Guangdong in 2007. As the PRC government authorities issue cord blood banking licenses in more regions, we believe that there will be significant growth opportunities in China. China has a population of approximately 1.3 billion. According to the National Bureau of Statistics of China, there were 15.9 million newborns in China in 2007, representing approximately 12.0% of newborns worldwide. In addition to the large number of newborns in China, we expect increased demand for our services to be driven by a number of factors, including increasing disposable income in urban areas; greater attention to health issues as people become more financially secure; emphasis on children under China's one-child policy; and heightened public awareness of the benefits associated with cord blood storage.


Principal activities

China Cord Blood Services Corporation (the "Company") and its subsidiaries (collectively the "Group") are principally engaged in the provision of umbilical cord blood storage and ancillary services in its cord blood banks in the People's Republic of China ("PRC"). As of March 31, 2009, the Group operates two cord blood banks in the Beijing municipality and Guangdong Province, the PRC.

The Group provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. The Group also tests, processes and stores donated cord blood, and provides matching services to the public for a fee.

The operation of cord blood banks in the PRC is regulated by certain laws and regulations. Cord blood bank operators in the PRC are required to possess a Blood Station Operation License. The licensing process for a cord blood bank is stringent and lengthy. The Ministry of Health of the PRC and the local Departments of Health have granted Blood Station Operation Licenses to cord blood banks that provide cord blood banking services. Cord blood banks collecting cord blood units from donors and providing matching cord blood units to the public without a duly obtained Blood Station Operation License face the risk of being shut down by the government. Only six cord blood banking licenses have been issued by the authorities as of March 31, 2009, of which the Company holds two. Due to the lack of a consistent and well-developed regulatory framework, operation in the cord blood banking industry in the PRC involves significant ambiguities, uncertainties and risks. The industry is highly regulated and any unilateral changes in regulations by the authorities may have a significant adverse impact on the Group's results of operations.

Latest financials

SEC Filings:



  1. It's tough to get shares right now..
  2. China has a one-child policy, which feeds into the desire for parents to do all they can to preserve the life of that one child.  Preservation of cord stem cells are a means to that end.
  3. Company is already profitable, and anticipates strong growth as more and more Chinese are educated about the benefits.
  4. As far as I know, CO is the only free-trading pure-play Chinese cord blood stock on the U.S. exchanges.
  5. There exists the potential for this stock to become a cult stock due to it being the one and only way to play cord blood storage in China.
  6. Warrants  provide an interesting alternative for leverage, and with an exercise price of $5 they are currently well in the money (CNDZF closing price on 9/4:  $7.10)

Insider Buys: 

SEC Transaction Summary - Last 6 Months - last checked April 17, 2010



Latest News:



List of Subsidiaries:

Exhibit 21.1 from F-1/A filed 11.18.09



China Cord Blood Services Corporation

Cayman Islands

China Stem Cells Holdings Limited

Cayman Islands

Beijing Jiachenhong Biological Technologies Co., Limited

PR China

China Stem Cells (South) Company Limited

British Virgin Islands

Guangzhou Municipality Tianhe Nuoya Bio-engineering Co. Ltd.


China Stem Cells (East) Company Limited

British Virgin Islands



19 November 2009 China Cord Blood Corp. NYSE Euronext Opening Bell




Transfer Agent:

Continental Stock Transfer & Trust Company
17 Battery Place, 8th Floor
New York 10004



All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.


Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.


Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:



PlusOneCoin Top Posts Free PlusOneCoin
No plusone'd posts yet. Be the first!
Post Subject
#431 Writeup on CO collinmcb 08/20/2021 04:49:01 PM
#430 In @ 2.92! Penny2Dime 06/11/2020 09:50:18 AM
#429 News: $CO Global Cord Blood Corporation Announces Receipt whytestocks 06/04/2019 03:00:49 PM
#428 Closed over the fifty day moving average on TruthSpeaker12 10/03/2017 04:03:32 PM
#427 failure to deliver error's today on china blood Qmark 08/24/2015 10:29:30 AM
#426 Do they accept the offer or wait for ATCrunch 08/13/2015 10:08:59 AM
#425 CO should accept the buyout. Maybe they know ATCrunch 08/12/2015 10:43:32 AM
#424 when does it hit 12? ATCrunch 08/11/2015 10:01:27 AM
#423 Watching Cbdpotential 05/03/2015 01:00:57 AM
#422 Lots of volume. going higher it seems. ATCrunch 04/24/2015 12:22:56 PM
#421 $CO recent news/filings stocktrademan 04/22/2015 11:49:28 AM
#420 Getting in for the long haul ATCrunch 04/21/2015 01:29:00 PM
#419 This combin Jfcross17 03/24/2015 11:34:50 AM
#418 Looks like its time again cowboyinvestor69 11/17/2014 01:14:00 AM
#417 Blood transfusions for Ebola. DoughRay 10/08/2014 02:13:30 PM
#416 $CO DD Notes ~ stocktrademan 08/26/2014 12:49:10 PM
#415 Getting attention... yotpope 02/21/2014 11:47:48 AM
#414 Anyone watching this one? Could get interesting with Surfjmk 11/13/2013 10:56:50 PM
#413 Look at the 6m and one year Trader Joey 08/21/2013 11:36:58 PM
#412 Hahahahaaaaa..... NOPE NOT EVEN CLOSE.... SOLD GREEN A Trader Joey 08/21/2013 11:18:17 PM
#411 Losing money here too ....A? ddls 08/21/2013 03:00:52 PM
#410 They are being very misleading on their website MinnieM 07/12/2013 09:39:35 PM
#409 I agree.... the kicker is no way to Trader Joey 07/12/2013 09:37:39 PM
#408 I sold mine off a long time ago. MinnieM 07/12/2013 01:54:59 PM
#407 Well seems like the tide is changing as Trader Joey 07/11/2013 09:18:49 PM
#406 No real posts on this stock for a Trader Joey 07/11/2013 08:51:05 PM
#405 ~ $CO ~ Daily Par Sar Buy Signal Penny Roger$ 07/09/2013 09:53:04 PM
#404 are they going to buy cbai asets on noode12 10/20/2012 06:05:48 PM
#403 China Cord Blood and Golden Meditech Holdings Limited mlkrborn 09/18/2012 01:30:53 PM
#402 I'm Glad there not! KABOOM locksflooring 08/01/2012 10:00:44 PM
#401 Thanks CO for the HUGE returns! Being Patient makingbiigdough 08/01/2012 10:19:20 AM
#400 Wowie blinkers88 08/01/2012 10:00:21 AM
#398 This Amendment No. 3 ( “Amendment”) relates to locksflooring 04/18/2012 08:54:15 PM
#397 Thank You, Karin dcwisc 03/30/2012 05:59:32 PM
#396 They are entirely different companies. Totally unrelated. MinnieM 03/30/2012 10:29:21 AM
#395 locks are china cord blood and cbai dcwisc 03/07/2012 09:52:36 PM
#394 Heading back to $4, I think it could Trader Joey 03/06/2012 01:37:59 AM
#393 ~ Monday! $CO ~ Earnings posted, pending or Penny Roger$ 02/25/2012 07:58:23 AM
#392 One Year $4.00 down to $2.00 locksflooring 01/08/2012 08:24:15 AM
#391 On December 19, 2011, China Cord Blood Corporation locksflooring 12/24/2011 10:40:46 PM
#390 China Cord Blood Corporation Announces Results of 2011 locksflooring 12/24/2011 10:39:39 PM
#389 SEC Filings: MinnieM 11/29/2011 04:07:47 AM
#388 China Cord Blood Corporation to Report Second Quarter mkendra 11/18/2011 08:45:25 AM
#387 Moving strong today. WTH?!?! Agent92260 11/16/2011 02:42:10 PM
#386 OK - there are 7 licenses issued in mkendra 11/15/2011 04:01:33 PM
#385 agreed. Agent92260 11/15/2011 02:35:14 PM
#384 The chart has indicated a downward trend since mkendra 11/15/2011 02:34:13 PM
#383 I also thought it was suppose to have Agent92260 11/15/2011 02:28:40 PM
#382 I don't. Q2 earnings are expected to be mkendra 11/15/2011 02:24:43 PM
#381 Anyone know why this is tanking? Agent92260 11/15/2011 01:18:59 PM
Post Subject